Vitamin D receptor gene polymorphisms and sex steroid secretion in girls with precocious pubarche in Southern Brazil: A pilot study

Journal of Endocrinological Investigation

Volumn 35, Issue 8, 2012, Pages 725-729

  Santos, B R ^a,b   Mascarenhas, L P G ^c   Satler, F ^a   Boguszewski, M C S ^c,d   Spritzer, P M ^a,b,d  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d National Institute of Hormones and Women's Health   (Brazil)

Author keywords

Adrenarche; Precocious pubarche; Single nucleotide polymorphism; Steroid hormones; Vitamin D; Vitamin D receptor

Indexed keywords

ESTRADIOL; TESTOSTERONE; VITAMIN D RECEPTOR;

APAI GENE; ARTICLE; BRAZIL; BSMI GENE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOKI GENE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HORMONE RELEASE; HUMAN; PILOT STUDY; PRECOCIOUS PUBERTY; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TAQI GENE; TESTOSTERONE BLOOD LEVEL;

BRAZIL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA; ESTRADIOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PUBERTY, PRECOCIOUS; RECEPTORS, CALCITRIOL; TESTOSTERONE;

EID: 84869231010     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7979     Document Type: Article

References (47)

1. Auchus RJ, Rainey WE. Adrenarche - physiology, biochemistry and human disease. Clin Endocrinol (Oxf) 2004, 60: 288-96. (Pubitemid 38297117)
2. Ibáñez L, Díaz R, López-Bermejo A, Marcos MV. Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism. Rev Endocr Metab Disord 2009, 10: 63-76.
3. Ibañez L, Potau N, Virdis R, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993, 76: 1599-603. (Pubitemid 23164385)
4. Vuguin P, Linder B, Rosenfeld RG, Saenger P, DiMartino-Nardi J. The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche. J Clin Endocrinol Metab 1999, 84: 2037-42. (Pubitemid 30647030)
5. Evliyaoglu O, Berberoglu M, Adiyaman P, Aycan Z, Ocal G. Evaluation of insulin resistance in Turkish girls with premature pubarche using the homeostasis assessment (HOMA) model. Turk J Pediatr 2007, 49: 165-70. (Pubitemid 47299800)
6. Maliqueo M, Sir-Petermann T, Pérez V, et al. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009, 94: 3282-8.
7. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 2000, 141: 1317-24. (Pubitemid 32269098)
8. Enjuanes A, Garcia-Giralt N, Supervia A, et al. Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments. Eur J Endocrinol 2003, 148: 519-26. (Pubitemid 36622158)
9. Krishnan AV, Swami S, Peng L, Wang J, Moreno J, Feldman D. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 2010, 151: 32-42.
10. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Endocrinol Metab Clin North Am 2010, 39: 255-69.
11. Mahmoudi T. Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil Steril 2009, 92: 1381-3.
12. Ranjzad F, Mahban A, Irani Shemirani A, et al. Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. J Assist Reprod Genet 2010, 28: 225-32.
13. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community- dwelling older adults: the Rancho Bernardo Study. Metabolism 2002, 51: 356-9. (Pubitemid 34232638)
14. Ortlepp JR, Metrikat J, Albrecht M, von Korff A, Hanrath P, Hoffmann R. The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 2003, 20: 451-4.
15. McGrath JJ, Saha S, Burne TH, Eyles DW. A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 2010, 121: 471-7.
16. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969, 44: 291-303.
17. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000, 314: 1-27.
18. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000, 320: 1240-3. (Pubitemid 30240471)
19. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357: 266-81.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16: 1215.
21. San-Pedro JI, Bilbao JR, De Nanclares GP, Vitoria JC, Martul P, Castano L. Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus. Autoimmunity 2005, 38: 439-44. (Pubitemid 41671553)
22. Ramos-Lopez E, Jansen T, Ivaskevicius V, et al. Protection from type 1 diabetes by vitamin D receptor haplotypes. Ann N Y Acad Sci 2006, 1079: 327-34. (Pubitemid 44968742)
23. Panierakis C, Goulielmos G, Mamoulakis D, Petraki E, Papavasiliou E, Galanakis E. Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clin Immunol 2009, 133: 276-81.
24. Nosratabadi R, Arababadi MK, Salehabad VA, et al. Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type-2 diabetes. Int J Immunogenet 2010, 37: 493-7.
25. Dilmec F, Uzer E, Akkafa F, Kose E, Van Kuilenburg ABP. Detection of vdr gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a turkish population. J Diabet Complicat 2010, 24: 186-91.
26. Dundar U, Solak M, Kavuncu V, et al. Evidence of association of vitamin D receptor Apa I gene polymorphism with bone mineral density in postmenopausal women with osteoporosis. Clin Rheumatol 2009, 28: 1187-91.
27. Selvaraj P, Vidyarani M, Alagarasu K, Prabhu Anand S, Narayanan PR. Regulatory role of promoter and 3′ UTR variants of vitamin D receptor gene on cytokine response in pulmonary tuberculosis. J Clin Immunol 2008, 28: 306-13.
28. Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D. Vitamin D status in Andhra Pradesh : a population based study. Indian J Med Res 2008, 127: 211-8. (Pubitemid 351936147)
29. Arabi A, El Rassi R, El-Hajj Fuleihan G. Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 2010, 6: 550-61.
30. Delvin EE, Lambert M, Levy E, et al. Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents. J Nutr 2010, 140: 987-91.
31. Melamed ML, Kumar J. Low levels of 25-hydroxyvitamin D in the pediatric populations: prevalence and clinical outcomes. Ped Health 2010, 4: 89-97.
32. Peters BS, Santos LC, Fisberg M, Wood RJ, Martini LA. Prevalence of vitamin D insufficiency in Brazilian adolescents. Ann Nutr Metab 2009, 54: 15-21.
33. Reinehr T, Sousa G, Alexy U, Kersting M, Andler W. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007, 157: 225-32. (Pubitemid 47233129)
34. Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008, 57: 183-91.
35. Ashraf A, Alvarez J, Saenz K, Gower B, McCormick K, Franklin F. Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents. J Clin Endocrinol Metab 2009, 94: 3200-6.
36. rd, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009, 124: e371-9.
37. Johnson MD, Nader NS, Weaver AL, Singh R, Kumar S. Relationships between 25-hydroxyvitamin D levels and plasma glucose and lipid levels in pediatric outpatients. J Pediatr 2010, 156: 444-9.
38. Hahn S, Haselhorst U, Tan S, et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006, 114: 577-83. (Pubitemid 46087264)
39. Wehr E, Pilz S, Schweighofer N, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 2009, 161: 575-82.
40. Yildizhan R, Kurdoglu M, Adali E, et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009, 280: 559-63.
41. Mahmoudi T, Gourabi H, Ashrafi M, Yazdi RS, Ezabadi Z. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertil Steril 2010, 93: 1208-14.
42. Glintborg D, Andersen M, Hagen C, Hermann AP. Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism. Clin Endocrinol (Oxf) 2005, 62: 683-91. (Pubitemid 40825938)
43. Accetta SG, Di Domênico K, Ritter CG, Ritter AT, Capp E, Spritzer PM. Anthropometric and endocrine features in girls with isolated premature pubarche or non-classical congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2004, 17: 767-73. (Pubitemid 38931079)
44. Witchel SF. Puberty and polycystic ovary syndrome. Mol Cell Endocrinol 2006, 254-255: 146-53. (Pubitemid 44041765)
45. Eyzaguirre FC, Bancalari R, Youlton R, et al. Precocious pubarche: experience in 173 cases. Rev Med Chil 2009, 137: 31-8.
46. Rauh M. Steroid measurement with LC-MS/MS. Application examples in pediatrics. J Steroid Biochem Mol Biol 2010, 121: 520-7.
47. Stanczyk FZ, Lee JS, Santen RJ. Standardization of steroid hormone assays: why, how, and when? Cancer Epidemiol Biomarkers Prev 2007, 16: 1713-9. (Pubitemid 47450498)